Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Cassia fistula*, commonly known as the Golden Shower Tree or Amaltas, is a medicinal plant native to the Indian subcontinent and Southeast Asia, widely utilized in traditional Ayurvedic and Siddha medicine. Its primary therapeutic application is as a stimulant laxative for the treatment of chronic functional constipation, often formulated as a syrup, capsule, or jelly, and frequently in combination with *Senna alexandrina* (e.g., the brand Naturetti). The plant's pods and leaves contain bioactive anthraquinone glycosides, such as sennosides and rhein, which promote bowel motility and intestinal secretion. Beyond its gastrointestinal applications, *Cassia fistula* is being investigated for its potential as an alpha-amylase and alpha-glucosidase inhibitor for diabetes management, an anti-inflammatory agent in rheumatoid arthritis via NF-kappa B pathway modulation, and for its antioxidant and wound-healing properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cassia fistula.